Impact of the antimetastatic drug Batimastat on tumor growth and PO2 measured by EPR oximetry in a murine mammary adenocarcinoma.
James
P E
PE
Radiology Department, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.
O'Hara
J A
JA
Grinberg
S
S
Panz
T
T
Swartz
H M
HM
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004578:Electron Spin Resonance Spectroscopy / Q000379:methods; D005260:Female; D015674:Mammary Neoplasms, Animal / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D051379:Mice; D008809:Mice, Inbred C3H; D010092:Oximetry / Q000379:methods; D010100:Oxygen / Q000032:analysis*; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013876:Thiophenes; D010649:Phenylalanine; C080985:batimastat; D008666:Metalloendopeptidases; D010100:Oxygen